tirzepatide is fda approved approves weight-loss drug Zepbound to treat sleep apnea – San Diego Union-Tribune FDA Approves Diabetes Drug Tirzepatide

Production of the hormone is affected by several factors including nutrition, sleep, exercise, stress, and the growth hormone itself

The SURMOUNT-OSA trials demonstrated tirzepatide reduced the apnea-hypopnea index (AHI) by 63-73% in adults with obesity and moderate-to-severe obstructive sleep apnea, approaching the efficacy of CPAP therapy

Personal or family history of medullary thyroid carcinoma or in patients with Multiple Endocrine Neoplasia syndrome type 2 Personal or family history of thyroid cancer Personal history of Suicidal thoughts or suicide attempts Personal history of Diabetic Retinopathy Personal history of Pancreatitis or gall bladder issues Currently pregnant or actively trying to get pregnant Known serious hypersensitivity to tirzepatide or any of the excipients in Zepbound Common side effects The most common side effects of Zepbound include nausea, diarrhea, vomiting, constipation, stomach (abdominal) pain, indigestion, injection site reactions, feeling tired, allergic reactions, belching, hair loss, and heartburn

Winner: Sermorelin Ready to buy